Report Includes:

  • An overview of technologies and global markets for the predisposition biomarkers
  • Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Information on recent key technical advances in different predisposition biomarkers, as well as the extent of adoption by commercial customers and regulatory authorities
  • Identification of key areas of growth and the key strategies of major players in the market
  • A look at recent diagnostic test developments and revelations as well as knowledge of how they will influence selected clinical markets